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ABSTRACT 
Introduction: The purpose of this study was 
to compare the dosimetries of three different 
external beam whole breast radiotherapy 
techniques: two-dimensional RT (2D-RT), three-
dimensional conformal RT (3D-CRT), and field-
in-field intensity-modulated RT (FiF-IMRT). 
In addition, we aimed to evaluate the patients 
who needed more or less complex treatment 
modalities. Methods: Thirty patients were 
included in the study. All the patients had early-
stage breast cancer and conserving surgery had 
been performed. Plans that employed the three 
techniques were generated for each patient. 
Dosimetric comparisons were conducted, and 
correlations with patient characteristics and 
dosimetric outcomes were analyzed. Results: The 
2D-RT technique was found to be suboptimal for 
treating the intact breast. Its dose homogeneity 
index (DHI) was 20.68. The authors were unable 
to define a patient characteristic in which 2D-RT 
dosimetry would perform better. FiF-IMRT 
was found to be the superior technique with a 
better homogeneity in the breast (DHI=9.35 and 
P=0.000002 when compared to 3D-CRT). When 
compared according to patient characteristics, 
again the FiF-IMRT planning is the best for all 
subgroups, but the DHI gets worse by increased 
breast volume and separation. While FiF-IMRT 
achieves better DHI in the breast, it has little effect 
on heart and lung doses. But the normal tissues’ 
volume (cc) that gets the 100% of the prescribed 
dose (V100) was lowered because of the treatment 
without wedges and scatter and with less monitor 
unit. Conclusions: 2D-RT could not be performed 
safely on the intact breast in any of the subgroups. 
FiF-IMRT is a superior technique for breast 
dosimetry, and normal tissue. For patients with 
large breast size or separation, further intensive 
techniques must be investigated. 
Keywords:  breast  cancer,  conformal 
radiotherapy, dosimetry, f ield-in-field 
radiotherapy
INTRODUCTION
Breast cancer is the most common malignancy 
in women.1 Breast-conserving surgery 
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followed by adjuvant radiotherapy (RT) is 
the standard treatment for early-stage breast 
cancer.2-4 Within the chaos and intensity of 
a clinic, some radiation oncologists prefer to 
treat patients with conventional methods to 
conserve the use of departmental resources. 
The rationale behind this practice may be 
that the breast is a palpable organ that can 
be easily targeted. The organs at risk, such 
as the ipsilateral lung and heart, are rarely 
subjected to doses that exceed the values 
stipulated by the International Commission 
on Radiation Units and Measurements (ICRU) 
report No. 50/62.5 In addition, these patients 
survive for long periods of time. Mortality 
and morbidity are technique- and dose-
dependent.6-9 Therefore, optimized radiation 
treatment planning plays a critical role in 
the care of breast cancer patients. There have 
been exciting advances in RT techniques, 
but generally, these techniques require more 
resources and a higher work volume.10
Although a few departments still use two-
dimensional RT (2D-RT), generally most 
departments use three-dimensional conformal 
RT (3D-CRT) as a standard.10 The development 
of accelerators with multi-leaf collimators (MLC) 
has facilitated the creation of newer techniques, 
such as field-in-field intensity-modulated RT 
(FiF-IMRT).11,12
In this clinic, 3D-CRT is used as the routine 
planning technique for treating the intact 
breast. However, two major questions are raised. 
First, do all patients require this conformal 
technique, or are there patients in whom the 
same dosimetry can be obtained with simple 
conventional planning techniques? Second, 
because technological developments offer new 
modalities, such as IMRT and FiF-IMRT (an 
easier method of IMRT), which patients and 
clinical scenarios are more appropriate for the 
use of these techniques?
METHODS
Patients
Thirty consecutive patients with in situ or 
early-stage breast cancer, who were undergoing 
adjuvant whole breast RT after conservative 
surgery, were prospectively enrolled in this 
study. This group included 15 patients with left-
sided involvement, and 15 patients with right-
sided involvement. All of the patients were node 
negative. Systemic therapy was administered by 
the medical oncologist if necessary. The clinical 
and treatment characteristics of the patient 
population are provided in Table 1. 
Treatment Planning
All of the patients were immobilized in the 
supine position on a breast-tilting board 
(MT-350; MED-TEC, Orange City, IA, USA) 
with the ipsilateral shoulder abducted and the 
head rotated slightly toward the contralateral 
side. The breast was palpated and marked 
with radio-opaque markers that were visible 
on the computerized tomography (CT) scan 
in the medial, lateral, superior, and inferior 
directions. In addition, the markers were used 
to denote the midline and mid-axillary planes 
in the central axis. High-resolution spiral 
CT scans (Toshiba Asteion Super 4, Toshiba 
Medical Systems Corporation, Tochigi, Japan) 
were obtained at a 5 mm slice thickness from 
the neck to the abdomen. CT data were then 
transferred to the treatment planning system 
(TPS) (Eclipse, version 8.0, Varian Medical 
Systems, Palo Alto, CA, USA) using a Digital 
Imaging and Communications in Medicine 
(DICOM) network connection. In addition, the 
Helios software package was used to generate the 
FiF-IMRT plans. Body and lung contours were 
created using an automatic contouring feature 
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of the TPS. The breast planning target volume 
and heart volume were determined by the same 
radiation oncologist. Breast tissue was contoured 
according to the breast tissue that was visible on 
CT (standard window level, 0 Hounsfield unit 
[HU]; with 500 HU) and the markers, 5 mm 
underneath the skin.
For 2D planning, two tangential collimated 
wedged fields, based on the chest wall, were used. 
Midline and mid-axillary markers were used as 
landmarks. The superior, inferior, medial, and 
lateral borders of both fields were 2 cm beyond 
the palpable breast tissue. The medial and lateral 
tangential fields were aligned and adjusted so 
that no more than 2 cm of the lung was included 
in the tangential portals. Physical wedges 
(15º, 30º, 45º, and 60º) were used. Generally 6 
MV photon beams were used for planning and 
if needed (ie, because of big separation, big 
breast size, etc) 18 MV photon beams were used. 
A minimum of two and a maximum of four fields 
were used. The dose distribution was observed in 
the central slice only, and doses were prescribed 
according to this slice.
For 3D-CRT, the breast volume was defined 
in all slices using the markers and the glandular 
breast tissue that were visible on the CT. 
Tangential fields that covered the contoured 
target volume with MLC blocks and wedges 
were designed. All possible combinations of 
wedges (wedge heel in/out right/left and wedge 
angles with physical and virtual wedges) were 
used to obtain the best planning. The plans 
were usually generated with 6 MV, but 6-18 MV 
energy combinations were used if necessary 
(ie, because of big separation, big breast size, 
etc). A minimum of two and a maximum of 
six tangential fields in different wedges and 
energies were used. Dose-volume histograms 
(DVH) of the breast, ipsilateral lung, and heart 
were taken into consideration when prescribing 
the reference isodose. The doses were prescribed 
according to the quality criteria in the ICRU 
reports.5 At least 95% of the planned target 
should receive at least 95% of the prescribed 
dose, while a homogeneous dose within 
95%-107% of the prescribed dose at target 
intended to obtain.
FiF-IMRT plans were created using the 
same tangential angles used in 3D-CRT. First, 
the two tangential fields without wedges were 
calculated, and then three additional subfields 
were generated by blocking 115%, 110%, and 
105% isodose clouds with MLC blocking. If the 
dose inhomogeneity did not reach 115%, then 
blocking began with a level 1%-2% lower than 
the highest dose, and two to three more subfields 
were generated with a 3%-5% dose reduction. 
Table 1. Clinical characteristics of the patient population.
Number of patients (n) 30
Median age (years) (min-max) 46 (27-63)
Median weight (kg) (min-max) 72.5 (48-109)
Median height (cm) (min-max) 158.0 (149-180)
Median BSA 1.75 (1.44-2.14)
Laterality
Right breast (n) 15





Median tumor size (cm) (min-max) 1.7 (0-5)




Median separation (cm) (min-max) 22.7 (17.8-31.0)
AJCC/UICC=American Joint Committee on Cancer/
Union Internationale Contre le Cantre le Cancer; 
BSA=body surface area.
Adv Ther (2011)  28(12):1114-1125. 1117
Figure 1 shows the medial portal of the main 
field and subfields of the FiF-IMRT plans. The 
prescribed dose for FiF-IMRT was the same for 
3D-CRT. The plans were generated with only 
6 MV photon beams. 
A 2.5 mm grid size and a pencil beam convolution 
algorithm were applied to the calculations for the 
plans. The heterogeneity corrections were turned 
on during all dose calculations.
These three techniques were evaluated in 
each patient. The treatment dose for each plan 
was 2 Gy/fraction with a total of 25 fractions. 
The treatment plans were reviewed by the same 
oncologist and physicist. The boost volumes were 
described, and the plans were made and performed 
for each patient; however, in this study, we did not 
plan to sum these additional therapies. All plans 
were compared over a total dose of 50 Gy.
The radiotherapies of the patients were made 
according to 3D-CRT, as it was the institute’s 
routine. The dosimetric comparisons were 
made only on computer plans and didn’t affect 
patient’s routine treatment, so the study did 
not need any Ethics Committee approval or 
informed consent.
Comparison of the Plans
Cumulative DVH (c-DVH) for the breasts were 
generated using mean doses received by 99%, 
98%, 95%, 90%, 85%, and 80% (D99, D98, D95, 
D90, D85, D80) of the breast volume and the 
mean volumes that received 80%, 85%, 90%, 
95%, 100%, and 105% (V80, V85, V90, V95, V100, 
V105) of the doses. Statistical comparisons of the 
techniques were conducted using the V95, V100, 
and V105 values, as well as the dose homogeneity 
index (DHI) and the conformity index (CI). 
The DHI is defined as follows:13
DHI=(D2-D98)/Dpres x 100%
D98 is the dose received by 98% of the target 
volume on the c-DVH. D2 is the dose received 
Figure 1. Field-in-field intensity-modulated radiotherapy planning, a right side breast. A. Main field, breast, and right 
lung can be seen as contoured. Lines represents field borders. B. First subfield, dose color wash level 110%, the multi-leaf 
collimators can be seen as closing the 110% dose cloud. C. Second subfield, dose color wash level 107%. D. Third subfield, 
dose color wash level 104%.

















111.9% 111.9% 111.9% 111.9%
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by 2% of the target volume on the c-DVH. 
Dpres is the prescribed dose.
The DHI should be less than 15 for an 
acceptable plan, and lower DHI values indicate 
a more homogeneous dose distribution.14
The following equation was used to calculate 
the CI for the three techniques:5
CI=TVref/TV x TV ref/Vref
TVref is the target volume (cm3) covered by 
the reference isodose. We used the prescribed 
dose for the reference dose. TV is the target 
volume (cm3), and Vref is the volume (cm3) 
covered by the reference isodose. 
The CI values ranged from 0-1. A higher CI value 
indicates higher dose conformity to the target.
The monitor unit counts (MU) required for 
treatment were recorded and compared between 
the techniques.
For organs at risk (OAR), a dosimetric 
comparison of the heart was conducted using 
V20, V5, and the mean dose. The ipsilateral 
lung was also evaluated using V20, V5, and the 
mean dose. The contralateral breast could not 
be contoured because the 70 cm bore diameter 
and narrow scan size of our CT scanner was not 
sufficient for overweight patients. Therefore, 
we compared the normal tissue volumes (body 
volume - target volume in cm3) that received the 
prescribed dose to evaluate the techniques.
Patient characteristics that might have been 
associated with a potential planning benefit were 
recorded. These included age, height, weight, 
breast volume, and breast separation.
Statistical Analysis
All statistical tests were performed using 
SPSS software 10.0.1 (SPSS Inc, Chicago, IL, 
USA). P≤0.05 (two-tailed) was defined as 
statistically significant. The pairwise Wilcoxon’s 
Figure 2. Dose color wash showing a patient  
receiving 50 Gy. A. Two-dimensional radiotherapy.  
B. Three-dimensional conformal radiotherapy.  
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signed-rank test was used to compare the 
treatment techniques. The relationship between 
patient characteristics and treatment outcomes 
were evaluated with the Mann-Whitney U test. 
RESULTS 
Dosimetric Evaluation
In this study, the dosimetric outcomes of 2D-RT, 
3D-CRT ,and FiF-IMRT in treating the intact 
breast were thoroughly investigated. 
A 50-Gy dose with the three different 
techniques in a patient is shown in Figure 2. 
The dosimetric comparisons of the 
treatment volume and MU for the three 
planning techniques are shown in Table 2. 
When comparing 2D-RT to FiF-IMRT, V105 was 
reduced from 15.12% to 9.62% (P=0.041013), 
V100 was increased from 79.94% to 92.29% 
(P=0.000004), and V95 increased from 94.91% to 
98.90% (P=0.000001). When comparing 3D-CRT 
to FiF-IMRT, V105 was reduced from 14.46% to 
9.62% (P=0.000978), V100 was increased from 
86.14% to 92.29% (P=0.000011), and V95 was 














V95 (%) 94.91±3.00 97.72±1.26 98.90±0.81 0.000016 0.000001 0.000006
V100 (%) 79.94±10.23 86.14±5.20 92.29±3.09 0.005832 0.000004 0.000011
V105 (%) 15.12±11.35 14.46±7.94 9.62±4.54 0.721246 0.041013 0.000978
CI 0.48±0.09 0.52±0.08 0.60±0.08 0.047162 0.000003 0.000002
DHI 20.68±17.82 12.20±2.20 9.35±1.75 0.000031 0.000002 0.000002
MU 290.27±44.46 278.30±28.94 228.46±7.94 0.104737 0.000002 0.000002
2D-RT=two-dimensional radiotherapy; 3D-CRT=three-dimensional conformal radiotherapy; CI= conformity index; 
DHI=dose homogeneity index; FiF-IMRT=field-in-field intensity-modulated radiotherapy; MU=monitor unit; 
Vx=treatment volume receiving x% or greater of the prescribed dose.
Figure 3. Cumulative dose-volume histograms of patients 
created with two-dimensional radiotherapy (2D-RT), three-
dimensional conformal radiotherapy (3D-CRT), and field-
in-field intensity-modulated radiotherapy (FiF-IMRT). The 

















increased from 97.72% to 98.90% (P=0.000006). 
The DHI in 2D-RT was found to be 20.68 and 
could not maintain the ICRU quality criteria. 
The best DHI was achieved with FiF-IMRT as 
1120 Adv Ther (2011)  28(12):1114-1125.
(267. 05 cm3) (P=0.023038) and 3D-CRT 
(269.53 cm3) (P=0.000358).
Predictive Patient Characteristics
Additionally, statistical analysis of patient 
characteristics and DHI was carried out by 
grouping the patient characteristics (age, weight, 
height, breast volume,and separation) into two 
groups, less than/equal to median and greater 
than median. FiF-IMRT was statistically superior to 
2D-RT and 3D-CRT, again in all age, weight, height, 
volume, and separation groups, but an interesting 
finding was that although it was still better than 
the 2D-RT’s and 3D-CRT’s DHIs, the DHI of 
FiF-IMRT got statistically worse with increased 
breast volume (8.57 to 10.15, P=0.007543) 
and increased breast separation (8.72 to 10.19, 
P=0.034939). The results are shown in Table 4. 
9.35 and better than 3D-CRT’s DHI of 12.20 
(P=0.000002). CI was closer to 1 in FiF-IMRT 
(0.60) and statistically better than 2D-RT (0.48, 
P=0.000003) and 3D-CRT (0.52, P=0.000002). 
The MU that were calculated to treat the patients 
were 290.27 MU in 2D-CRT and 278.30 MU in 
3D-CRT (P>0.05). It was significantly lowered to 
228.46 MU in FiF-IMRT (P=0.000002).
The c-DVH values of the three treatment 
techniques are shown in Figure 3.
The average dosimetric characteristics of 
the OAR for the three planning techniques 
are presented in Table 3. FiF-IMRT only seems 
to reduce the mean dose of the ipsilateral lung 
when compared with 3D-CRT (P=0.034119), 
however, the heart dosimetry did not differ 
significantly among the techniques. The V100 
of the normal tissue was reduced with 
FiF-IMRT (214.81 cm3) compared to 2D-RT 















V20 (%) 14.11±5.85 14.80±5.20 13.93±5.00 0.813011 0.544006 0.058406
V5 (%) 19.22±6.22 19.87±5.79 19.46±5.54 0.765519 0.922484 0.318439
Mean dose (Gy) 7.77±3.00 8.29±2.35 7.81±2.32 0.813016 0.757676 0.034119
Heart (n=15)
Left sided only
V20 (%) 5.51±4.99 8.11±5.13 8.10±4.78 0.131809 0.151956 0.300170
V5 (%) 10.04±6.88 13.39±7.39 13.26±8.04 0.088402 0.211476 0.198122
Mean dose (Gy) 4.42±2.52 5.33±2.43 5.17±2.41 0.201188 0.495520 0.172761
Normal tissues
V100 (cm3) 267.05±151.34 269.53±133.16 214.81±125.79 0.781263 0.023038 0.000358
2D-RT=two-dimensional radiotherapy; 3D-CRT=three-dimensional conformal radiotherapy; Vx= treatment volume 
receiving x or greater of the prescribed dose; FiF-IMRT=field-in-field intensity-modulated radiotherapy.
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DISCUSSION 
The objective of this study was to compare 
the dosimeters of three different radiotherapy 
techniques, 2D-RT, 3D-CRT, and FiF-IMRT, 
and to identify patient characteristics that can 
predict which patients would benefit the most 
from an intensive technique. 
It is difficult to directly compare the 
calculated mean values to the data from the 
literature because most studies do not include 
brief technical notes, and there is great 
variability in the definitions of the planned 
targets. The margins provided for breast clinical 
target volume (CTV) to planned target volume 
(PTV) range from 0 mm to 30 mm,15 however, 















≤46  15.36±4.63 12.53±1.95 9.46±1.47 0.005611 0.000293 0.000351
>46 27.64±25.43 11.76±2.52 9.22±2.14 0.029766 0.001473 0.001468
P values 0.109864 0.368291 0.737106 - - -
Weight (kg)
≤72.5 22.34±22.71 12.00±1.95 9.02±1.26 0.005385 0.000654 0.000653
>72.5 19.03±11.69 12.39±2.49 9.70±2.14 0.002162 0.000655 0.000805
P values 0.467920 0.561316 0.455000 - - -
Height (cm)
≤158 26.56±22.99 12.75±2.20 9.90±2.02 0.000531 0.000437 0.000530
>158 13.97±2.84 11.58±2.13 8.73±1.17 0.021911 0.000981 0.000981
P values 0.024542 0.120142 0.141743 - - -
Breast volume (cc)
≤706.1 21.96±22.83 11.83±2.22 8.57±1.49 0.004506 0.000655 0.000655
>706.1 19.41±11.55 12.57±2.21 10.15±1.93 0.002162 0.000655 0.000805
P values 0.267097 0.187268 0.007543 - - -
Seperation (cm)
≤22.7 22.18±21.47 11.62±1.76 8.72±1.07 0.004847 0.000293 0.000293
>22.7 18.73±12.08 12.96±2.56 10.19±2.15 0.001871 0.001474 0.001871
P values 0.620582 0.094466 0.034939 - - -
2D-RT=two-dimensional radiotherapy; 3D-CRT=three-dimensional conformal radiotherapy; FiF-IMRT=field-in-field 
intensity-modulated radiotherapy.
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in this study, we did not use any margins. The 
disease stages of the patients varied, and this 
affected doses and volumes. In addition, the 
volumetric parameters that were compared are 
very different, and different ways of calculating 
the DHI and CI were employed. Therefore, the 
results of this comparison were considered with 
other comparison studies in the literature. 
Based on these results, among the three 
techniques, 2D-RT was inferior and could not 
maintain ICRU 50/62 quality criteria, which 
indicates that it is a suboptimal technique 
for treating the intact breast. Munshi et al.16
reported that breast planning based solely on 
a single isocentric contour is an appropriate 
technique for patients with small breasts. In our 
study we grouped the breast volume as less than/
equal to and greater than the median volume 
and DVH of less than/equal to median breast 
volume was still bigger than 15 and statistically 
was not different from the greater than median 
breast volume group. We were unable to define a 
subgroup in which the target volume dosimetry 
outcomes with 2D-RT were similar to more 
conformal techniques. 
3D-CRT obtained a better dosimetry, DHI, and 
CI of the target volume compared to 2D-CRT, 
but it did not produce any dose reduction to the 
OAR. There are conflicting data about 3D-CRT’s 
effect on the OAR. Teh et al.17 analyzed irradiated 
lung volumes in 2D-RT and 3D-CRT planning 
in Stage I-III breast cancer patients. No dose 
reduction was found with 3D-CRT planning, 
and higher doses were recorded compared to 
2D planning (V20 in 2D = 14%, in 3D = 22%). 
Leonardi et al.18 reported a significantly reduced 
mean lung volume in Stage I breast carcinoma 
with 3D-CRT planning compared to 2D-RT 
planning (4.5% vs. 5.4, P=0.034). Kong et al.19
concluded that the use of 3D-CRT planning for 
tangential breast irradiation does not decrease 
the heart and lung dose. The 3D-CRT treatment 
planning with anatomy guidance that was 
individualized to each patient resulted in a 
better breast dosimetry compared to 2D-RT, 
which is consistent with the literature.20-22
The FiF-IMRT has the most favorable dose 
distrubition in our study. There have been 
several reports on the use of FiF-IMRT to 
improve dose distribution.11,12,23-27 Barnett et al.26
reported that breast dosimetry can be 
significantly improved with FiF-IMRT with little 
impact on radiotherapy resources. In a study 
by Ercan et al.,12 the targeted volumes received 
105% and 110% of the prescribed dose, and the 
DVHs were found to be reduced. Smith et al.11
compared different tangential planning 
techniques for the breast and concluded that 
IMRT planning significantly improved the 
DHI of the target volume compared to 2D-RT. 
They also noted that there were no significant 
differences in DHI between FiF-IMRT and the 
other two IMRT techniques, which indicates 
that FiF-IMRT is as effective as the other 
IMRT techniques. Donovan et al.9 found a 
reduced breast appearance change with 5-year 
photographs in 3D IMRT when compared to 2D 
treatment (40% vs. 58%, P=0.008). In this study, 
we found statistically significant improvements 
in all evaluated dosimetric parameters for 
target with FiF-IMRT compared to 2D-RT and 
conformal 3D-CRT.
Ohashi et al.27 examined the OAR and 
reported that FiF-IMRT improved regional node 
coverage while decreasing doses to the heart, 
lungs, and other normal tissue compared to the 
modified tangential irradiation technique. Ercan 
et al.12 evaluated the heart volumes that are 
irradiated with 10, 20, and 30 Gy and reported 
that FiF-IMRT showed a significant decrease 
compared to the conventional 3D technique. 
The results were again in favor of FiF-IMRT when 
the ipsilateral lung volumes that received 10, 20, 
or 30 Gy were examined. Smith et al.11 reported 
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consumed with planning, but generally the time 
passed with FiF-IMRT was less than 3D-CRT, 
because for 3D-CRT all the possible wedges and 
energies angles for dose optimization were tried, 
but in FiF-IMRT only the subfields were created 
and so the time passed for only creating them 
and modifying their field weight. It did not take 
more time than 3D-CRT planning.
CONCLUSION
FiF-IMRT achieves a better dose homogeneity 
and conformity in breast than 3D-CRT and 
2D-RT. 2D-RT is a suboptimal technique for 
treating the intact breast. The authors could 
not define a subgroup for which this treatment 
could be offered. FiF-IMRT has nearly no 
impact on doses for lung and heart, and it 
better protects normal tissue by reducing the 
treatment time and scatter. Its superiority 
decreases with bigger breast volumes and 
separation. More intensive techniques could be 
used for these patients. 
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that IMRT lowers heart V30 and lung V20, but 
there were no differences in the equivalent 
uniform dose to the heart or lung with IMRT 
compared to conventional techniques. In this 
study, the authors found a decreased mean 
dose to the ipsilateral lung with FiF-IMRT 
only. In addition, the V100 of normal tissue 
was significantly reduced with FiF-IMRT. This 
statistically significant reduction in the V100 of 
normal tissue could be explained by the reduced 
scatter dose and the treatment time. The use of 
virtual wedges that were compared with physical 
wedges has been shown to reduce the scattered 
dose to the contralateral breast.10
In the FiF-IMRT planning technique, with 
increasing volume and breast separation, the 
dose homogeneity in the breast worsened in this 
study. The shoulder of the curve decreased, and 
the tail of the curve elongated (V95 decreased 
and V5 increased). Herrich et al.24 showed that 
FiF-IMRT’s DVH does not worsen with larger 
breast volumes. Moody et al.,28 in a study that 
included more than 559 breast cancer patients, 
found a significant correlation between breast 
size and dose inhomogeneity. Aref et al.22 did 
not find a correlation between breast volume 
and homogeneity in the conformal planning 
technique. Although the benefits of FiF-IMRT 
planning techniques are reduced in larger 
breasts and wide separation, this technique was 
still the best of the three. This reduction can be 
explained by the use of only 6 MV. For these 
patients, forward IMRT with more than two 
optimized gantry angles and higher energies 
could be a solution. 
The IMRT plans generally require more MU, 
but FiF-IMRT significantly reduced the MU 
counts required for treatment.12 We also found 
this significant reduction when using FiF-IMRT 
planning compared to 2D-RT and 3D-CRT.
In the arrangement of the planning the 
authors decided not to evaluate the time 
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